DK1003724T3 - Substituerede quinolin-derivater med antiviral virkning - Google Patents

Substituerede quinolin-derivater med antiviral virkning

Info

Publication number
DK1003724T3
DK1003724T3 DK97915425T DK97915425T DK1003724T3 DK 1003724 T3 DK1003724 T3 DK 1003724T3 DK 97915425 T DK97915425 T DK 97915425T DK 97915425 T DK97915425 T DK 97915425T DK 1003724 T3 DK1003724 T3 DK 1003724T3
Authority
DK
Denmark
Prior art keywords
pct
quinoline derivatives
antiviral effect
substituted quinoline
date
Prior art date
Application number
DK97915425T
Other languages
English (en)
Inventor
Reinhard Kirsch
Joerg-Peter Kleim
Guenther Riess
Bernd Rosenstock
Manfred Roesner
Irvin Winkler
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK1003724T3 publication Critical patent/DK1003724T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97915425T 1996-04-04 1997-03-25 Substituerede quinolin-derivater med antiviral virkning DK1003724T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19613591A DE19613591A1 (de) 1996-04-04 1996-04-04 Substituierte-Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
PCT/EP1997/001496 WO1997037977A1 (de) 1996-04-04 1997-03-25 Substituierte-chinolin-derivate mit antiviraler wirkung

Publications (1)

Publication Number Publication Date
DK1003724T3 true DK1003724T3 (da) 2003-05-05

Family

ID=7790532

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97915425T DK1003724T3 (da) 1996-04-04 1997-03-25 Substituerede quinolin-derivater med antiviral virkning

Country Status (10)

Country Link
US (1) US6114349A (da)
EP (1) EP1003724B1 (da)
JP (1) JP4231107B2 (da)
AT (1) ATE232519T1 (da)
AU (1) AU2291297A (da)
DE (2) DE19613591A1 (da)
DK (1) DK1003724T3 (da)
ES (1) ES2192675T3 (da)
PT (1) PT1003724E (da)
WO (1) WO1997037977A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077850A (en) * 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
GB9930061D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Quinolone compounds for use in treating viral infections
EP1318995B1 (en) * 2000-09-19 2006-03-08 Centre National De La Recherche Scientifique (Cnrs) Pyridinone and pyridinethione derivatives having hiv inhibiting properties
WO2003051878A1 (en) * 2001-12-14 2003-06-26 Merck Frosst Canada & Co. Quinolinones as prostaglandin receptor ligands
EP1664046B1 (en) * 2003-09-19 2009-06-17 Gilead Sciences, Inc. Aza-quinolinol phosphonate integrase inhibitor compounds
AU2005249363A1 (en) * 2004-04-14 2005-12-15 Zhenhong R. Cai Phosphonate analogs of HIV integrase inhibitor compounds
WO2007022946A1 (de) 2005-08-21 2007-03-01 Abbott Gmbh & Co. Kg Heterocyclische verbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
EP2074099A1 (en) * 2006-09-29 2009-07-01 Tibotec Pharmaceuticals Ltd. Quinolinone derivatives
CN113087664B (zh) * 2021-03-22 2022-03-11 云南中烟工业有限责任公司 一种喹啉生物碱类化合物及其制备方法与应用
WO2023004188A2 (en) * 2021-07-23 2023-01-26 The Research Institute At Nationwide Children's Hospital Inhibiting intracellular pathogens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59209965D1 (de) * 1991-04-15 2002-10-17 Aventis Pharma Gmbh Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
GB9125515D0 (en) * 1991-11-29 1992-01-29 Merck Sharp & Dohme Therapeutic agents
TW304945B (da) * 1992-06-27 1997-05-11 Hoechst Ag
JPH0692939A (ja) * 1992-09-16 1994-04-05 Kyowa Hakko Kogyo Co Ltd イミダゾール誘導体

Also Published As

Publication number Publication date
ATE232519T1 (de) 2003-02-15
JP4231107B2 (ja) 2009-02-25
DE59709321D1 (de) 2003-03-20
AU2291297A (en) 1997-10-29
US6114349A (en) 2000-09-05
WO1997037977A1 (de) 1997-10-16
ES2192675T3 (es) 2003-10-16
PT1003724E (pt) 2003-06-30
EP1003724B1 (de) 2003-02-12
EP1003724A1 (de) 2000-05-31
DE19613591A1 (de) 1997-10-09
JP2000508299A (ja) 2000-07-04

Similar Documents

Publication Publication Date Title
CY2509B1 (en) New thiazole derivatives with phosphodiesterase-inhibitting effect
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
NO971766D0 (no) Anvendelsen av dioksomorfoliner for bekjempning av endoparasitter, nye dioksomorfoliner samt deres fremstilling
HRP20080664A2 (en) Substituted pyridine herbicides
ATE248175T1 (de) Epothilonderivate und ihre verwendung als antitumormittel
DE59703471D1 (de) Betain-geminitenside auf der basis von aminen
MX9305894A (es) Azaquinoxalinas, procedimientos para su preparacion y su empleo.
TR200000595T2 (tr) 2,3-Diaril-pirazolo[1,5-B]piridazinler türevleri, bunların hazırlanması ve bunların siklooksijenaz 2 (COX-2) inhibitörleri olarak kullanılması.
DK0889886T3 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
PT941221E (pt) Dihidrobenzofuranos substituidos como inibidores de fosfodiesterase (pde)
DK0937074T3 (da) Benzonaphthyridiner som bronkiale terapeutiske midler
PT998460E (pt) Novos derivados de tetrazole
DK1003724T3 (da) Substituerede quinolin-derivater med antiviral virkning
ES2165052T3 (es) Procedimiento para la preparacion de derivados de pirimidina.
MX9306995A (es) Derivados de acido orto-etenilfenilacetico sustituidos.
SE9402241D0 (sv) Inhibitor
DE59509727D1 (de) Uracilderivate
ATE154601T1 (de) 4-amino-2-(hetero)aryl-butanamide verwenbar als 5-ht1a-antagonisten